Loading, Please Wait...
DENVER, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Trent Carman as chief financial officer, effective October 22nd, 2018.
Carman comes to Assure with more than 20 years of CFO experience, including over 15 years of healthcare industry expertise for both public and private organizations. Most recently he served as CFO for Vivos Therapeutics and prior to that was CFO at Air Methods Corp. (formerly Nasdaq: AIRM) for over 13 years.
While at Air Methods, the largest air medical and air tourism operator in the United States, Carman was instrumental in driving the company’s rapid growth through multiple M&A transactions and prudent financial management. Under his financial guidance, Air Methods completed five major acquisitions totaling approximately $565 million and secured $2.5 billion in financing. During his tenure, Carman was pivotal in growing Air Method’s enterprise value from approximately $100 million to over $2 billion.
“Trent will be an invaluable asset to our organization with his wealth of knowledge and financial expertise in the healthcare industry and in particular revenue cycle billing,” said John Farlinger, executive chairman and interim CEO of Assure. “As our platform’s reputation grows and we continue to expand into new states and verticals, Trent’s background in leading the financial aspects of organizations through periods of rapid revenue growth will be integral to our success.”
Commenting on his appointment, Carman stated, “Assure has a unique, turnkey platform that has earned an impressive reputation across the neuromonitoring marketplace as they continue to increase their footprint throughout the United States. I look forward to leveraging my prior experience leading rapidly growing companies in the healthcare industry to implement the necessary financial and operational strategies conducive to Assure’s expansion efforts.”
Carman began his professional career at KPMG in 1984. He holds a Master of Business Administration, with an emphasis in finance, from Indiana University.
Concurrent with his appointment, Carman will receive 400,000 options of Assure pursuant to the Employee stock option plan of Assure. The particular terms of the options will be disclosed to the market once the options are granted. The grant of these options remains subject to the approval of the TSX Venture Exchange.
About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company’s website at www.assureneuromonitoring.com.
This news release contains certain statements that may constitute forward-looking information under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance or achievements that Assure anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information. Such information may involve, but is not limited to, comments with respect to strategies, expectations, planned operations and future actions of the Company, including but not limited to the Company obtaining regulatory approval to commence trading. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the forgoing) be taken, occur, be achieved, or come to pass. Forward-looking information is based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of Assure to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors may be based on information currently available to Assure, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs regarding future growth, results of operations, future capital (including the amount, nature and sources of funding thereof) and expenditures. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement.
Investors are cautioned that, except as disclosed in the Filing Statement any information released or received with respect to the reverse take-over may not be accurate or complete and should not be relied upon. Trading in the securities of the Corporation should be considered highly speculative.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities of the Corporation have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
John Farlinger, Executive Chairman
Assure Holdings Corp.
Cody Slach, Managing Director
Liolios Investor Relations